Munafa Stock Market Course + Intraday & FNO calls 
Neurocrine Biosciences (NBIX) Technical (Analysis) Reports Neurocrine Biosciences ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Neurocrine Biosciences (NBIX)
Technical Analysis Report for NASDAQ stock NBIX Neurocrine Biosciences. Dated: 11 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock NBIX Neurocrine Biosciences then click here. or read Experts views on Neurocrine Biosciences or Forecast & share price targets of Neurocrine Biosciences
Neurocrine Biosciences Opened at 157.20 and Closed at: 156.22, which is -0.22% of previous session's close. It moved within a range of 156.12 and 159.67
The session was a Bearish session with an average volume of 890800, which is -0.48% of previous session's volumes.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 4 days back on short term averages
Support for tomorrow is 154.4 and resistance for tomorrow is 157.95
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 155, 153.79 resistance for tomorrow's hourly charts is 158.55, 160.89
10 Day SMA for Neurocrine Biosciences (NBIX) is 155.97 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Neurocrine Biosciences (NBIX) is 155.05 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Neurocrine Biosciences (NBIX) is 164.86 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 159.66 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Neurocrine Biosciences is 148.02 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Neurocrine Biosciences is at 155.05 and 200 DMA is at 148.02, while 50 DMA and 100 DMA are at 164.86 and 159.66 respectively
Neurocrine Biosciences (NBIX) moving average of 20 SMA is at 155.05 and 20 EMA is at 157.01
| Date | Closing Price | 20 SMA | 20 EMA |
| 11 Fri Sep | 156.22 | 155.05 | 157.01 |
| 10 Thu Sep | 156.57 | 154.78 | 157.09 |
| 09 Wed Sep | 155.14 | 154.78 | 157.14 |
| 08 Tue Sep | 155.13 | 155.12 | 157.35 |
| 04 Fri Sep | 155.64 | 155.61 | 157.58 |
| 03 Thu Sep | 158.35 | 156 | 157.78 |
Neurocrine Biosciences (NBIX) moving average of 50 SMA is at 164.86 and 50 EMA is at 159.8
| Date | Closing Price | 50 SMA | 50 EMA |
| 11 Fri Sep | 156.22 | 164.86 | 159.8 |
| 10 Thu Sep | 156.57 | 165.22 | 159.95 |
| 09 Wed Sep | 155.14 | 165.45 | 160.09 |
| 08 Tue Sep | 155.13 | 165.71 | 160.29 |
| 04 Fri Sep | 155.64 | 166.01 | 160.5 |
| 03 Thu Sep | 158.35 | 166.27 | 160.7 |
Neurocrine Biosciences (NBIX) moving average of 100 SMA is at 159.66 and 100 EMA is at 157.39
| Date | Closing Price | 100 SMA | 100 EMA |
| 11 Fri Sep | 156.22 | 159.66 | 157.39 |
| 10 Thu Sep | 156.57 | 159.41 | 157.41 |
| 09 Wed Sep | 155.14 | 159.15 | 157.43 |
| 08 Tue Sep | 155.13 | 158.91 | 157.48 |
| 04 Fri Sep | 155.64 | 158.69 | 157.53 |
| 03 Thu Sep | 158.35 | 158.42 | 157.57 |
Neurocrine Biosciences (NBIX) moving average of 200 SMA is at 148.02 and 200 EMA is at 150.08
| Date | Closing Price | 200 SMA | 200 EMA |
| 11 Fri Sep | 156.22 | 148.02 | 150.08 |
| 10 Thu Sep | 156.57 | 147.96 | 150.02 |
| 09 Wed Sep | 155.14 | 147.88 | 149.95 |
| 08 Tue Sep | 155.13 | 147.82 | 149.9 |
| 04 Fri Sep | 155.64 | 147.74 | 149.85 |
| 03 Thu Sep | 158.35 | 147.65 | 149.79 |
Neurocrine Biosciences has performed better than Xeris Pharmaceuticals in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Voyager Therapeutics in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Vertex Pharmaceuticals in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Veru Inc in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Supernus Pharmaceuticals in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Neuronetics Inc in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Pulmatrix Inc in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Prothena Corporation in short term. Holding Neurocrine Biosciences could be a better choice for now!
Pulse Biosciences has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Pulse Biosciences, about 16.95% more returns!
Moleculin Biotech has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Moleculin Biotech, about 15.74% more returns!
Neurocrine Biosciences has performed better than Innoviva Inc in short term. Holding Neurocrine Biosciences could be a better choice for now!
Icon Plc has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Icon Plc, about 1.49% more returns!
Galectin Therapeutics has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Galectin Therapeutics, about 11.37% more returns!
Neurocrine Biosciences has performed better than Adma Biologics in short term. Holding Neurocrine Biosciences could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Alnylam Pharmaceuticals, about 6.47% more returns!
Neurocrine Biosciences has performed better than Citius Pharmaceuticals in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Dexcom Inc in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences Technical analysis of indicators
Price action analysis of Neurocrine Biosciences (NBIX) based on a short term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Neurocrine Biosciences stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Neurocrine Biosciences in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Neurocrine Biosciences Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Neurocrine Biosciences in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Neurocrine Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 155.8 and Neurocrine Biosciences NBIX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Neurocrine Biosciences NBIX stock. Volume based technical analysis of Neurocrine Biosciences NBIX stock is negative.
Neurocrine Biosciences Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock NBIX Neurocrine Biosciences These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NBIX Experts View which covers a lot of information including buying and selling signals
NBIX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Neurocrine Biosciences or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Neurocrine Biosciences (NBIX) Technical (Analysis) Reports Neurocrine Biosciences ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
